Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 7

    China Biotech Keeps Fans Despite Wild Swings, High Valuation.. Report

    China Biotech Keeps Fans Despite Wild Swings, High Valuation.. Report

    Medical Dialogues Bureau24 Oct 2018 9:00 AM IST
    New Delhi: Chinese biotechnology stocks have been hit by a wave of bad news since the summer.Bloomberg reports that the shares plunged about 30 per...
    GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

    GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

    Medical Dialogues Bureau23 Oct 2018 10:03 AM IST
    New Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended...
    Johnson & Johnson profit beats, lifts forecast on cancer drug demand

    Johnson & Johnson profit beats, lifts forecast on cancer drug demand

    Medical Dialogues Bureau17 Oct 2018 9:10 AM IST
    Johnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for...
    You are man of honour, come with viable plan to pay Daiichi: HC to Shivinder Singh

    You are man of honour, come with viable plan to pay Daiichi: HC to Shivinder Singh

    Medical Dialogues Bureau12 Oct 2018 2:21 PM IST
    New Delhi: The Delhi High Court on Thursday directed former Ranbaxy Laboratories Ltd. promoter Shivinder Singh to pay the money owed to Japanese...
    ICRA upgrades long-term credit rating of Fortis Healthcare

    ICRA upgrades long-term credit rating of Fortis Healthcare

    Medical Dialogues Bureau21 Sept 2018 1:01 PM IST
    New Delhi: Fortis Healthcare Thursday said rating agency ICRA has upgraded its long-term credit rating as it has repaid the overdue debt obligations...
    Apollo Hospitals Q1 net up 71 percent at Rs 60 crore

    Apollo Hospitals Q1 net up 71 percent at Rs 60 crore

    Ruby Khatun Khatun18 Aug 2018 10:00 AM IST
    New Delhi: Apollo Hospitals posted a 71.02 increase in its standalone profit after tax (PAT) at Rs 60.2 crore for the first quarter ended June 30.The...
    Abbott India net profit rises 70.78 percent at Rs 82.40 crores

    Abbott India net profit rises 70.78 percent at Rs 82.40 crores

    Ruby Khatun Khatun17 Aug 2018 10:15 AM IST
    Mumbai: Pharma Major, Abbott India Ltd has posted a rise of 70.78 percent in its net profit at Rs 82.40 crores for the quarter ended June 30, 2018, as...
    Sun Pharma Q1 net profit at Rs 982 crore

    Sun Pharma Q1 net profit at Rs 982 crore

    Ruby Khatun Khatun16 Aug 2018 10:15 AM IST
    New Delhi: Sun Pharmaceutical Industries reported a consolidated net profit of Rs 982.51 crore for the June quarter of 2018-19.The company had posted...
    Cipla Q1 net profit up 10 percent at Rs 451 crore

    Cipla Q1 net profit up 10 percent at Rs 451 crore

    Ruby Khatun Khatun11 Aug 2018 10:30 AM IST
    New Delhi: Drug major Cipla posted 10 percent increase in its consolidated net profit to Rs 451 crore for the first quarter ended June 30, driven by...
    Natco Pharma Q1 net profit up 93 percent to Rs 181 crore

    Natco Pharma Q1 net profit up 93 percent to Rs 181 crore

    Ruby Khatun Khatun10 Aug 2018 11:00 AM IST
    New Delhi: Drug firm Natco Pharma reported a 93.27 percent rise in its consolidated net profit to Rs 181.1 crore for the quarter ended June 30 mainly...
    Lupin Q1 net profit dips 43 percent at Rs 203 crore

    Lupin Q1 net profit dips 43 percent at Rs 203 crore

    Ruby Khatun Khatun10 Aug 2018 10:45 AM IST
    New Delhi: Drug firm Lupin reported 43.37 percent decline in its consolidated net profit at Rs 202.76 crore for the first quarter ended June 30, hit...
    Strides Pharma Q1 net loss at Rs 4 crore

    Strides Pharma Q1 net loss at Rs 4 crore

    Ruby Khatun Khatun9 Aug 2018 10:15 AM IST
    New Delhi: Strides Pharma Science reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30.The company had posted a net profit...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok